An application has been made to the UEMS EACCME for CME accreditation of this event.
Dermatologists, Rheumatologists, Nurses, PAs, Researchers and other healthcare professionals.
This activity will address treatment advances for inflammatory skin diseases affecting adults and children. The comprehensive program will cover technological/scientific/medical advances in treatment of Psoriasis; Vitiligo; Atopic Dermatitis; Pemphigus; Blistering Disorders; Chronic Urticaria; Alopecia Areata and other conditions. The program will include world-renowned scientists discussing evolving concepts in treating inflammatory skin diseases as well as the implications in targeted therapeutics.
After participation in this activity, the learner should be able to:
- Identify and analyze new and important studies on inflammatory skin diseases
- Apply the most current research on the diagnosis and treatment of inflammatory skin diseases, including psoriasis and eczema
- Compare and contrast new targeted therapies for inflammatory skin diseases, and apply them to their practice
- Recognize, manage and appropriately treat unusual presentations of inflammatory skin diseases, based on newly developed personalized approaches
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Icahn School of Medicine at Mount Sinai and The Austrian Academy of Sciences.
The Icahn School of Medicine at Mount Sinai is accredited by the ACCME to provide continuing medical education for physicians.
Icahn School of Medicine at Mount Sinai designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.